Evidence map›Paper›PMID 40204963›Full record

ArticleScientific reports2025

Monocyte-to-HDL cholesterol ratio (MHR) as a novel Indicator of gout risk.

Liangyu Mi, Xiaoyao He, Jinfang Gao, Ke Xu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liangyu Mi *Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Xiaoyao He *Department of Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030032, China.
Jinfang GaoThird Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Ke XuThird Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China. xukesxbqeh@hotmail.com.

Funding

Four "batches" innovation project of invigorating medical through science and technology of shanxi province 2023XM002Fundamental Research Program of Shanxi Province 202303021211218National Natural Science Foundation of China 81871292Shanxi Province Postgraduate Practice Innovation Project 2023SJ135
6 · The paper itself

Abstract

Gout, a common inflammatory arthritis, is associated with elevated monocyte levels and reduced high-density lipoprotein cholesterol (HDL-C). However, the relationship between the monocyte-to-HDL-C ratio (MHR) and gout risk remains unexplored. This study investigates the association between MHR and gout risk, examines the role of MHR in gout with comorbid renal dysfunction, and provides a theoretical basis for gout prevention and treatment. Using data from the National Health and Nutrition Examination Survey (NHANES, 2005-2016), a cross-sectional analysis was conducted to assess the correlation between MHR levels and gout. Multiple logistic regression, subgroup analyses, and exploration of nonlinear relationships were employed. Among 7247 participants, MHR was significantly higher in gout patients (0.54 ± 0.31) compared to non-gout patients (0.47 ± 0.24). After adjustments, MHR was significantly associated with gout risk (OR = 1.6, 95%CI 1.1-2.2, P = 0.012). Subgroup analyses revealed a positive correlation between MHR and gout risk in males, Mexican Americans, married individuals, those with insufficient physical activity, and diabetic patients. In gout patients with renal dysfunction, MHR was 0.6 ± 0.5, showing a stronger positive association (OR = 7.4, 95%CI 2.2-25.3, P = 0.001). The prevalence of gout with renal dysfunction in the highest MHR quartile was 1.7 times higher than in the lowest quartile (OR = 2.7, 95%CI 1.1-6.7, P = 0.028). These findings suggest a significant positive correlation between MHR and gout risk in U.S. adults, as well as a link between MHR and the severity of renal dysfunction in gout patients. MHR may serve as a valuable indicator for assessing gout risk and its complications, highlighting the need for further large-scale prospective studies to confirm these results.

Indexed as

Cholesterol, HDLGoutMonocytesAdultAgedBiomarkersCross-Sectional StudiesFemaleHumansMaleMiddle AgedNutrition SurveysRisk FactorsBiomarkersCholesterol, HDL

Identifiers

PMID40204963
PMCPMC11982197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.